Bronwyn has over 20 years executive experience in health technology commercialisation, venture capital, capital raising and industry advocacy. In 2017 she founded ANDHealth, an organisation that supports digital health companies in Australia by providing education, resources, non-dilutive funding and mentorship to help them navigate the complexities of the healthcare industry.

‍
ANDHealth is now one of Australia’s leading health technology commercialisation organisations with companies participating in its flagship ANDHealth+ program raising $19.70 in new capital and generating $6.70 in new revenues for every dollar invested. ANDHealth manages over $30M in public and private commitments to digital health commercialisation, and provides specialist support to a further $100M of funding managed by Brandon Capital.

‍
Bronwyn has been a Member of the Council of the National Health & Medical Research Council since 2021. She is also currently a Non-Executive Director of Lumos Diagnostics Ltd (ASX.LDX) alongside a number of other advisory roles.

Lisa Suennen stands as one of the most influential figures in digital health and health technology investment, with a career spanning over 35 years at the intersection of healthcare, technology and venture capital. Renowned for her strategic vision, operational expertise and advocacy for innovation, she has played a pivotal role in shaping the digital health landscape globally.

Lisa is currently the Managing Partner at American Heart Association Ventures, where she oversees a platform of four venture funds investing across the healthcare spectrum. Her focus spans digital health, medical devices and solutions for cardiovascular and brain health, as well as broader determinants of health.

Previously, Lisa served as General Partner at Manatt Ventures, Psilos Group and GE Ventures. At GE Ventures, she directed the healthcare venture fund, evaluating thousands of pitches each year and making selective, high-impact investments in digital health, including AI-driven medical imaging, telemedicine and remote patient monitoring. At Psilos Group, she played a key role in early investments in companies such as Definity Health, ActiveHealth Management and Extend Health, all of which achieved significant exits, further establishing her as a leading healthcare investor.

Lisa’s investment philosophy centres on solutions that address real customer needs and navigate the complexities between patients, payers and providers. Named one of Business Insider’s nine digital health power players, she is widely recognised for her ability to bridge startups and large healthcare organisations. She has also been a critical architect in launching and scaling digital health initiatives such as the Go Red for Women Venture Fund and Cardeation Capital, pioneering disease-focused investment in the nonprofit sector.

Lisa chairs the International Investment Committee for Australia’s ANDHealth Digital Health Accelerator Fund, supporting early-stage digital health startups and international growth. She also led the Scientific Advisory Board for NASA’s Translational Research Institute for Space Health, demonstrating her commitment to advancing health innovation globally.

As Co-founder and CEO of CSweetener, Lisa created a mentorship platform for rising healthcare leaders, later acquired by the HLTH Foundation. She is a leading advocate for women in health tech, providing mentorship, writing on industry challenges and hosting podcasts to amplify female entrepreneurs’ voices.

Lisa is a Fellow of the Aspen Institute’s Health Innovators Fellowship and teaches healthcare innovation and investment at UC Berkeley Haas School of Business. She authors the widely read Venture Valkyrie blog and is an internationally recognised speaker and author on digital health and investment trends.